test

Biocon Arm Gets US Regulator Nod For New Drug To Treat Eye Disorders

The approval of Yesafili marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the US.

from NDTV Profit https://ift.tt/5XDWsl2
Biocon Arm Gets US Regulator Nod For New Drug To Treat Eye Disorders Biocon Arm Gets US Regulator Nod For New Drug To Treat Eye Disorders Reviewed by aamira sultan on May 21, 2024 Rating: 5

No comments:

Powered by Blogger.